{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:59:45Z","timestamp":1762865985865},"reference-count":60,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Gene Medicine"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Transcriptional targeted suicide gene (SG) therapy driven by the insulinoma\u2010associated 1 (INSM1) promoter makes it possible to target suicide toxin production and cytotoxicity exclusively to small cell lung cancer (SCLC) cells and tumors. It remains to be determined whether acquired chemoresistance, as observed in the majority of SCLC patients, desensitizes SCLC cells to INSM1 promoter\u2010driven SG therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A panel of SCLC cell lines resistant to clinically relevant chemotherapeutics was characterized regarding the expression of proteins involved in response to chemotherapy and regarding INSM1 promoter activity. Sensitivity towards INSM1 promoter\u2010driven SG therapy was tested using different systems: Yeast cytosine deaminase\u2010uracil phosphoribosyl transferase (YCD\u2010YUPRT) in combination with the prodrug 5\u2010fluorocytosine (5\u2010FC) or <jats:italic>Escherichia coli<\/jats:italic> nitroreductase (NTR) together with the bromomustard prodrug SN27686.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The chemoresistant cell lines displayed heterogeneous expression profiles of molecules involved in multidrug resistance, apoptosis and survival pathways. Despite this, the INSM1 promoter activity was found to be unchanged or increased in SCLC chemoresistant cells and xenografts compared to chemosensitive variants. INSM1 promoter\u2010driven SG therapy with YCD\u2010YUPRT\/5\u2010FC or NTR\/SN27686, was found to induce high levels of cytotoxicity in both chemosensitive and chemoresistant SCLC cells. Moreover, the combination of INSM1 promoter\u2010driven YCD\u2010YUPRT\/5\u2010FC therapy and chemotherapy, as well as the combination of INSM1 promoter\u2010driven YCD\u2010YUPRT\/5\u2010FC and NTR\/SN27686 therapy, was observed to be superior to single agent therapy in chemoresistant SCLC cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Collectively, the present study demonstrates that targeted SG therapy is a potent therapeutic approach for chemoresistant SCLC patients, with the highest efficacy achieved when applied as combination SG therapy or in combination with standard chemotherapy. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jgm.2630","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T11:11:25Z","timestamp":1336734685000},"page":"445-458","source":"Crossref","is-referenced-by-count":14,"title":["Single agent\u2010 and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells"],"prefix":"10.1002","volume":"14","author":[{"given":"Signe R.","family":"Michaelsen","sequence":"first","affiliation":[{"name":"Department of Radiation Biology The Finsen Center National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla L.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Radiation Biology The Finsen Center National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell","family":"Sehested","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Diagnostic Centre National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Cramer","sequence":"additional","affiliation":[{"name":"Department of Radiation Biology The Finsen Center National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas T.","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Radiation Biology The Finsen Center National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam V.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Auckland Cancer Society Research Centre School of Medical Sciences University of Auckland  Auckland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans S.","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Radiation Biology The Finsen Center National University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055386"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.3.355"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.4859"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8111-5"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.241"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.06.019"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685084"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02897284"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2009.11.006"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1158\/1535-7163.327.3.3","article-title":"Down\u2010regulation of Bcl\u20102 is associated with cisplatin resistance in human small cell lung cancer H69 cells","volume":"3","author":"Kumar BS","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10096"},{"key":"e_1_2_6_13_1","first-page":"913","article-title":"Inhibition of phosphatidylinositol 3\u2010kinase\u2010Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy","volume":"1","author":"Krystal GW","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2005.n.002"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1586\/era.09.10"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7054"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700887"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i44.6910"},{"key":"e_1_2_6_19_1","first-page":"3813","article-title":"In vivo cancer gene therapy by adenovirus\u2010mediated transfer of a bifunctional yeast cytosine deaminase\/uracil phosphoribosyltransferase fusion gene","volume":"60","author":"Erbs P","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-3057"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a021473"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701088"},{"key":"e_1_2_6_24_1","first-page":"255","article-title":"Consequences of chemoresistance for the herpes simplex virus thymidine kinase\/ganciclovir\u2010induced bystander effect in a human small cell lung cancer cell line model","volume":"25","author":"Van Dillen IJ","year":"2005","journal-title":"Anticancer Res"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700980"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.09.066"},{"key":"e_1_2_6_27_1","first-page":"6891","article-title":"Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow\u2010up","volume":"48","author":"Berendsen HH","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_6_28_1","first-page":"2913","article-title":"Establishment and identification of small cell lung cancer cell lines having classic and variant features","volume":"45","author":"Carney DN","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00695993"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90093-J"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.376"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.154"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2008.06.872"},{"key":"e_1_2_6_34_1","first-page":"5674","article-title":"Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin","volume":"52","author":"Twentyman PR","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.58"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1797::AID-CNCR7>3.0.CO;2-9"},{"key":"e_1_2_6_37_1","first-page":"459","article-title":"Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP\u201016 (etoposide)\u2010selected H69 small cell lung cancer cells","volume":"55","author":"Brock I","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_38_1","first-page":"115","article-title":"Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer","volume":"3","author":"Campling BG","year":"1997","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161210789941865"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.247"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00069-X"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-416-6_4"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568011054222364"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/7.4.394"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e3280a02f43"},{"key":"e_1_2_6_46_1","first-page":"465","article-title":"Cellular models of drug\u2010 and radiation\u2010resistant small cell lung cancer","volume":"24","author":"Davey RA","year":"2004","journal-title":"Anticancer Res"},{"key":"e_1_2_6_47_1","first-page":"3299","article-title":"Mechanism of multidrug resistance of human small cell lung cancer cell line H446\/VP","volume":"123","author":"Wang YL","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.2741\/1592"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205939"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-125971"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.21629"},{"key":"e_1_2_6_52_1","first-page":"1943","article-title":"Transcriptional gene expression profiling of small cell lung cancer cells","volume":"63","author":"Pedersen N","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5648"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2762"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg542"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.09.019"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910330509"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1138"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3033"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.5.370"},{"key":"e_1_2_6_61_1","first-page":"6501","article-title":"Inhibition by 5\u2010fluorouracil of cis\u2010diamminedichloroplatinum(II)\u2010induced DNA interstrand cross\u2010link removal in a HST\u20101 human squamous carcinoma cell line","volume":"52","author":"Esaki T","year":"1992","journal-title":"Cancer Res"}],"container-title":["The Journal of Gene Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjgm.2630","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jgm.2630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T04:57:45Z","timestamp":1700542665000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jgm.2630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1002\/jgm.2630"],"URL":"https:\/\/doi.org\/10.1002\/jgm.2630","archive":["Portico"],"relation":{},"ISSN":["1099-498X","1521-2254"],"issn-type":[{"value":"1099-498X","type":"print"},{"value":"1521-2254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}